News

Cone Health's Vision for Healthcare Equity Wins Top Award

Cone Health's Vision for Healthcare Equity Wins Top Award

Cone Health's Recognition for Healthcare Equity

In a significant achievement for healthcare equity, Cone Health has earned the esteemed 2025 Bernard J. Tyson Award for its ongoing efforts to address and eliminate healthcare disparities. The award, named in honor of Bernard J. Tyson, who was the former Chairman and CEO of Kaiser Permanente, recognizes organizations that implement effective strategies to reduce gaps in healthcare access and outcomes.

Addressing Healthcare Disparities

Cone Health, a not-for-profit healthcare network in the Piedmont Triad region, has shown exceptional commitment to improving health outcomes among its patients, particularly focusing on underserved populations. In their comprehensive initiative, Cone Health tackled the alarming rate of uncontrolled hypertension, a condition that disproportionately affects Black patients within the community.

The Initiative's Impact

In response to the high rates of hypertension, Cone Health initiated a thorough investigation into healthcare access among its patient population. The findings revealed a critical need for targeted action, leading to the establishment of a multidisciplinary approach to hypertension management.

A Team-Based Care Model

The team-based care model incorporated a variety of healthcare professionals, including physicians, pharmacists, and social workers, to break down systemic barriers. These barriers included access to medications, affordability, transportation services, and health literacy — factors that often affect vulnerable communities the most.

Results of the Program

Data collected from the initiative highlighted a success story from October 2023 through August 2024. The overall blood pressure control rate among all patients improved by nearly 2%, increasing from 69.8% to 71.7%. For Black patients, the improvements were even more pronounced, with control rates rising by 5.6 percentage points from 64.9% to a notable 70.5%.

Enhancements Through Pharmacist Engagement

One of the most effective strategies in this initiative was the assignment of community pharmacists to work closely with a targeted cohort of over 130 patients. Through virtual visits and ongoing support, significant improvements in blood pressure control were achieved. Notably, among all patients in this cohort, control rates surged from just 7.2% to an impressive 64.5%. Likewise, Black patients experienced a remarkable rise in control from 5.2% to 63.5%, with an average blood pressure reduction of approximately -15.6/-6.1 mmHg.

Statements of Praise

Leadership at both Joint Commission and Kaiser Permanente have acknowledged Cone Health's exemplary dedication to health equity. Dr. Jonathan B. Perlin, president and CEO of Joint Commission, commended the initiative for targeting the root causes of healthcare disparities. Additionally, Dr. Andrew Bindman from Kaiser Permanente lauded Cone Health's work as a crucial example of how addressing external factors can significantly enhance health outcomes.

The Way Forward for Healthcare Equity

“We are truly honored to receive this recognition,” stated Cone Health’s interim CEO, Bernie Sherry. “Our approach, led by Dr. Olu Jegede and his dedicated team, proves that improving care for those most in need benefits all patients, enhancing the healthcare system as a whole.”

Scalable Success

The scalability of the program was emphasized by the selection panel of the Tyson Award, who noted that the tools and workflows developed by Cone Health were not only shared within their own system but have also been adapted by participating independent partners in the Triad HealthCare Network. This showcases the potential for broader implementation in communities facing similar challenges.

Conclusion

The award ceremony took place at UNIFY 2025™, a prominent healthcare summit where industry leaders convened to tackle pressing issues in healthcare quality. As applications for the 2026 Tyson Award open in the near future, several organizations will aim to follow in Cone Health’s footsteps, inspired by their commitment to equity in healthcare.

Frequently Asked Questions

What is the Bernard J. Tyson Award?

The Bernard J. Tyson Award honors healthcare organizations for their accomplishments in reducing healthcare disparities and improving health outcomes for vulnerable populations.

How did Cone Health improve blood pressure control?

Cone Health implemented a multidisciplinary team approach focusing on systemic barriers to care, which included engaging community pharmacists in patient management.

What were the results of Cone Health's initiative?

Blood pressure control for all patients improved by 2% in less than a year, with even greater improvements seen among Black patients, achieving a 5.6% increase in control rates.

Who recognized Cone Health for their efforts?

Joint Commission and Kaiser Permanente jointly awarded Cone Health for its dedication to healthcare equity and successful health improvement strategies.

When will applications for the next Tyson Award open?

Applications for the 2026 Tyson Award are expected to open early next year, providing opportunities for organizations to showcase their initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 198

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 206

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading

Top 5 Most Recently Viewed Articles

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 558

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
ParaZero Technologies Achieves Nasdaq Compliance Milestone

Updated Category News Views 130

ParaZero Technologies Regains Compliance with Nasdaq Standards Recent developments in the aerospace sector have highlighted the impressive strides made by ParaZero Technologies Ltd. (Nasdaq: PRZO), an innovator in safety systems for drones and urban air mobility vehicles. The company has reached a significant milestone, regaining compliance with Nasdaq’s minimum bid...

Continue Reading
Revolutionizing Semiconductor Design with AI Integration

Updated Category News Views 389

Ricursive Intelligence Launches Groundbreaking AI Lab Ricursive Intelligence is setting a new standard in semiconductor design with the introduction of its innovative AI lab. This initiative aims to seamlessly blend artificial intelligence with chip creation to expedite progress within the tech landscape. Major Funding and Valuation Boost The company recently raised an...

Continue Reading
Craneware plc Publishes a Key Trading Disclosure Notice

Updated Category News Views 219

Introduction to Craneware plc's Trading Disclosure Craneware plc, a prominent player in the healthcare technology space, has officially announced a significant trading disclosure following the rules established in the Takeover Code. This notification serves as an important communication to stakeholders about recent trading activities that involve exempt principal traders...

Continue Reading
Stocks to Consider Amidst Global Market Uncertainty

Updated Category News Views 150

The Current Market Landscape As geopolitical tensions rise, markets are experiencing undercurrents of uncertainty. Recent tariff threats have sent ripples through global financial markets, particularly affecting investor confidence in stocks. The atmosphere is becoming increasingly cautious, with many investors wondering which stocks might shield their portfolios during...

Continue Reading